Rainmaker: Extreme Energy Pre-Workout
Pre-Workout that activates 5 key areas for working out!
Extreme energy is great, but there is more to great pre-workout than that. Most products today are over-formulated in one area and leave you with a lackluster workout. Have you ever found yourself adding other supplements to your pre-workout to make your workout better? These days, you almost have to.
Axis Labs® formulated Rainmaker, a fully formulated pre-workout. Rainmaker™ is your perfectly formulated pre-workout, made for your perfect workout! We combined proven ingredients like Nitrosigine®, Hydromax®, Creatine MagnaPOWER® and Teacrine®. We are passionate to MOTIVATE you not only to get through your workout, but also to make you WANT to workout!
Nitrosigine® has been clinically shown to boost nitric oxide (NO) levels. Nitric oxide is a key factor in promoting the relaxation of smooth muscle in blood vessels, increasing blood flow to working muscles. Nitrosigine® supplementation significantly increased arginine blood levels for up to 3 hours and silicon levels for up to 1.5 hours. The Nitrosigine® complex was shown in pre-clinical (animal) studies to be absorbed efficiently, raising plasma arginine and silicon levels. Silicon can strengthen and provide flexibility to your arterial walls, helping to increase blood flow. Silicon is difficult to absorb through dietary intake, but Nitrosigine® was shown in pre-clinical studies to dramatically increase silicon absorption. Nitrosigine® provides the benefits of arginine and silicon, plus additional enhanced benefits from its unique combination.
HydroMax™ is the industry’s first stable, highly concentrated form of powdered glycerol (65%) that offers a unique combination of greater potency and function, offering exceptional hydration in a uniquely optimized proprietary blend of glycerol and silica. The ability of HydroMax™ to increase the concentration of fluid in the blood and tissue within the body (hyperhydration) lends itself to potential enhancements in the benefits of multiple athletic and fitness applications. Powdered forms of glycerol typically utilized in sports nutrition are in the form of glycerol monostearate (GMS) at a potency of 5-12%.
Magnesium creatine chelate can protect the creatine from this cyclization in the stomach’s acid environment, and make higher quantities of the active form of creatine available to the muscles for energy. Beneficially, the magnesium creatine chelate will serve to provide the body with bioavailable magnesium (an ingested dose of unchanged mineral that reaches the body’s circulation system). It will also work intensely to increase the muscle’s ability to generate and recycle energy in the form of ATP. Creatine MagnaPower®, magnesium creatine chelate, is patented by Albion Laboratories® and proven by scientific research. Creatine MagnaPower performs better than creatine monohydrate. Creatine MagnaPower is the most advanced creatine ever created in science labs, and proven by scientific research.
Theacrine (as TeaCrine®) is a potent extract containing a concentrated dose of pure theacrine (>98%) for use in dietary supplements. This nature-identical compound works with the body's natural metabolic processes to prep the body for more intense, longer lasting workouts by delivering energy to muscles, increasing mental clarity, and improving mood and motivation. TeaCrine® is concentrated nature-identical theacrine that delivers energy shown to last up to 6 hours.
Advantra Z is derived from the immature bitter orange fruit, a GRAS (generally recognized as safe) food ingredient traditionally used for dietary and medicinal purposes. Stringent harvesting and manufacturing methods capture and preserve the optimal amount of natural p-synephrine - a stable synephrine isomer and Advantra Z's dominant amine that exhibits twice the physiological activity as synthetic p-synephrine - ensuring consistent quality and standardized p-synephrine levels in every batch. Laboratory analyses confirm Advantra Z is devoid of m-synephrine, a synthetic isomer found in nasal decongestants, which can increase blood pressure and heart rate in humans.
Piperine, in the patented form of BioPerine® enhances the body's natural thermogenic activity-hence the term Thermonutrient®. This enhancement may be explained as a means of increasing the thermal energy sufficient to "power up" the mechanism related to thermogenesis. This in turn results in increased metabolic processes that creates a "demand" for "supply" of a broad range of nutrients that contribute to metabolism, i.e. vitamins, minerals, herbals, amino acids, etc. It is as if BioPerine® activates a metabolic paddle wheel, of sorts, that selectively provides a more efficient mode of nutrient transportation into the blood.
- Review at bodybuilding.com - Review by KBoss302
Write Your Own Review
Anomasiri W. S. Sanguanrungsirikul and P. Saichandee 2004. Low dose creatine supplementation enhances sprint phase of 400 meters swimming performance. J Med Assoc Thai 87 Suppl 2: S228-32.
Avery N. G. J. L. Kaiser M. J. Sharman T. P. Scheett D. M. Barnes A. L. Gomez W. J. Kraemer and J. S. Volek 2003. Effects of vitamin E supplementation on recovery from repeated bouts of resistance exercise. J Strength Cond Res 17(4): 801-9.
Baylis A. D. Cameron-Smith and L. M. Burke 2001. Inadvertent doping through supplement use by athletes: assessment and management of the risk in Australia. Int J Sport Nutr Exerc Metab 11(3): 365-83.
Brudnak M. A. 2004. Creatine: are the benefits worth the risk? Toxicol Lett 150(1): 123-30.
Burke DG, Smith-Palmer T, Holt LE, Head B, Chilibeck PD. The effect of 7 days of creatine supplementation on 24-hour urinary creatine excretion. J Strength Cond Res 2001 Feb;15(1):59-62
Chromiak J. A. B. Smedley W. Carpenter R. Brown Y. S. Koh J. G. Lamberth L. A. Joe B. R. Abadie and G. Altorfer 2004. Effect of a 10-week strength training program and recovery drink on body composition muscular strength and endurance and anaerobic power and capacity. Nutrition 20(5): 420-7.
Constantin-Teodosiu D, Greenhaff PL, Gardiner SM, Randall MD, March JE, Bennett T. Attenuation by creatine of myocardial metabolic stress in Brattleboro rats caused by chronic inhibition of nitric oxide synthase. Br J Pharmacol 1995 Dec;116(8):3288-92
Dangott B, Schultz E, Mozdziak PE. Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int J Sports Med 2000 Jan;21(1):13-6
Dash AK, Sawhney A. A simple LC method with UV detection for the analysis of creatine and creatinine and its application to several creatine formulations. J Pharm Biomed Anal 2002 Jul 31;29(5):939-45
Dawson B. G. J. Henry C. Goodman I. Gillam J. R. Beilby S. Ching V. Fabian D. Dasig P. Morling and B. A. Kakulus 2002. Effect of Vitamin C and E supplementation on biochemical and ultrastructural indices of muscle damage after a 21 km run. Int J Sports Med 23(1): 10-5.
Dempsey R. L. M. F. Mazzone and L. N. Meurer 2002. Does oral creatine supplementation improve strength? A meta-analysis. J Fam Pract 51(11): 945-51.
Dempsey RL, Mazzone MF, Meurer LN. Does oral creatine supplementation improve strength? A meta-analysis.
Earnest CP, Almada AL, Mitchell TL. High-performance capillary electrophoresis-pure creatine monohydrate reduces blood lipids in men and women. Clin Sci (Lond) 1996 Jul;91(1):113-8
Falk D. J. K. A. Heelan J. P. Thyfault and A. J. Koch 2003. Effects of effervescent creatine ribose and glutamine supplementation on muscular strength muscular endurance and body composition. J Strength Cond Res 17(4): 810-6.
Feldman E. B. 1999. Creatine: a dietary supplement and ergogenic aid. Nutr Rev 57(2): 45-50.
Fillmore C. M. L. Bartoli R. Bach and Y. Park 1999. Nutrition and dietary supplements. Phys Med Rehabil Clin N Am 10(3): 673-703.
Froiland K. W. Koszewski J. Hingst and L. Kopecky 2004. Nutritional supplement use among college athletes and their sources of information. Int J Sport Nutr Exerc Metab 14(1): 104-20.
Greenwood M. J. Farris R. Kreider L. Greenwood and A. Byars 2000. Creatine supplementation patterns and perceived effects in select division I collegiate athletes. Clin J Sport Med 10(3): 191-4.
Hoffman J. R. J. Cooper M. Wendell J. Im and J. Kang 2004. Effects of beta-hydroxy beta-methylbutyrate on power performance and indices of muscle damage and stress during high-intensity training. Strength Cond Res 18(4): 747-52.
Hoffman J. R. J. R. Stout M. J. Falvo J. Kang and N. A. Ratamess 2005. Effect of low-dose short-duration creatine supplementation on anaerobic exercise performance. J Strength Cond Res 19(2): 260-4.
Hoffman R. M. T. M. Hess C. A. Williams D. S. Kronfeld K. M. Griewe-Crandell J. E. Waldron P. M. Graham-Thiers L. S. Gay R. K. Splan K. E. Saker and P. A. Harris 2002. Speed associated with plasma pH oxygen content total protein and urea in an 80 km race. Equine Vet J Suppl(34): 39-43.
Huang S. H. K. Johnson and A. L. Pipe 2006. The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games. Clin J Sport Med 16(1): 27-33.
Javierre C. J. R. Barbany V. M. Bonjorn M. A. Lizarraga J. L. Ventura and R. Segura 2004. Creatine supplementation and performance in 6 consecutive 60 meter sprints. J Physiol Biochem 60(4): 265-71.
Kingsley M. I. D. Wadsworth L. P. Kilduff J. McEneny and D. Benton 2005. Effects of phosphatidylserine on oxidative stress following intermittent running. Med Sci Sports Exerc 37(8): 1300-6.
Kocak S. and U. Karli 2003. Effects of high dose oral creatine supplementation on anaerobic capacity of elite wrestlers. J Sports Med Phys Fitness 43(4): 488-92.
Kraemer W. J. and J. S. Volek 1999. Creatine supplementation. Its role in human performance. Clin Sports Med 18(3): 651-66 ix.
Kreider R. B. 2003. Effects of creatine supplementation on performance and training adaptations. Mol Cell Biochem 244(1-2): 89-94.
Kristiansen M. R. Levy-Milne S. Barr and A. Flint 2005. Dietary supplement use by varsity athletes at a Canadian university. Int J Sport Nutr Exerc Metab 15(2): 195-210.
LaBotz M. and B. W. Smith 1999. Creatine supplement use in an NCAA Division I athletic program. Clin J Sport Med 9(3): 167-9.
Lawler JM, Barnes WS, Wu G, Song W, Demaree S. Direct antioxidant properties of creatine. Biochem Biophys Res Commun 2002 Jan 11;290(1):47-52
Maughan R. 2002. The athlete's diet: nutritional goals and dietary strategies. Proc Nutr Soc 61(1): 87-96.
McGuine T. A. J. C. Sullivan and D. A. Bernhardt 2002. Creatine supplementation in Wisconsin high school athletes. Wmj 101(2): 25-30.
McGuine T. A. J. C. Sullivan and D. T. Bernhardt 2001. Creatine supplementation in high school football players. Clin J Sport Med 11(4): 247-53.
Mendes R. R. I. Pires A. Oliveira and J. Tirapegui 2004. Effects of creatine supplementation on the performance and body composition of competitive swimmers. J Nutr Biochem 15(8): 473-8.
Mendes R. R. and J. Tirapegui 2002. Creatine: the nutritional supplement for exercise - current concepts. Arch Latinoam Nutr 52(2): 117-27.
Metzl J. D. E. Small S. R. Levine and J. C. Gershel 2001. Creatine use among young athletes. Pediatrics 108(2): 421-5.
Morrison L. J. F. Gizis and B. Shorter 2004. Prevalent use of dietary supplements among people who exercise at a commercial gym. Int J Sport Nutr Exerc Metab 14(4): 481-92.
Odoom JE, Kemp GJ, Radda GK. The regulation of total creatine content in a myoblast cell line. Mol Cell Biochem 1996 May 24;158(2):179-88
Ostojic S. M. 2004. Creatine supplementation in young soccer players. Int J Sport Nutr Exerc Metab 14(1): 95-103.
Parise G, Mihic S, MacLennan D, Yarasheski KE, Tarnopolsky MA. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J Appl Physiol 2001 Sep;91(3):1041-7
Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 2001 Jun;53(2):161-76
Poortmans JR, Francaux M. Adverse effects of creatine supplementation: fact or fiction? Sports Med 2000 Sep;30(3):155-70
Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc 1999 Aug;31(8):1108-10
Preen D. B. Dawson C. Goodman S. Lawrence J. Beilby and S. Ching 2002. Pre-exercise oral creatine ingestion does not improve prolonged intermittent sprint exercise in humans. J Sports Med Phys Fitness 42(3): 320-9.
Rawson E. S. and J. S. Volek 2003. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. J Strength Cond Res 17(4): 822-31.
Robinson TM, Sewell DA, Casey A, Steenge G, Greenhaff PL. Dietary creatine supplementation does not affect some haematological indices, or indices of muscle damage and hepatic and renal function. Br J Sports Med 2000 Aug;34(4):284-8
Robinson TM, Sewell DA, Hultman E, Greenhaff PL. Role of submaximal exercise in promoting creatine and glycogen accumulation in human skeletal muscle. J Appl Physiol 1999 Aug;87(2):598-604
Ronsen O. J. Sundgot-Borgen and S. Maehlum 1999. Supplement use and nutritional habits in Norwegian elite athletes. Scand J Med Sci Sports 9(1): 28-35.
Rosenshtraukh LV, Anyukhovsky EP, Beloshapko GG, Undrovinas AI, Fleidervish IA, Paju AY, Glukhovtsev EV. Some mechanisms of nonspecific antiarrhythmic action of phosphocreatine in acute myocardial ischemia. Biochem Med Metab Biol 1988 Dec;40(3):225-36
Saab G, Marsh GD, Casselman MA, Thompson RT. Changes in human muscle transverse relaxation following short-term creatine supplementation. Exp Physiol 2002 May;87(3):383-9
Santos M. G. J. M. Gonzalez de Suso A. Moreno M. Cabanas and C. Arus 2004. Muscular energetic metabolism study in athletes using 31P-MRS. Rev Assoc Med Bras 50(2): 127-32.
Schedel JM, Tanaka H, Kiyonaga A, Shindo M, Schutz Y. Acute creatine ingestion in human: consequences on serum creatine and creatinine concentrations. Life Sci 1999 Oct 29;65(23):2463-70
Schroder H. E. Navarro J. Mora D. Galiano and A. Tramullas 2001. Effects of alpha-tocopherol beta-carotene and ascorbic acid on oxidative hormonal and enzymatic exercise stress markers in habitual training activity of professional basketball players. Eur J Nutr 40(4): 178-84.
Silber M. L. 1999. Scientific facts behind creatine monohydrate as sport nutrition supplement. J Sports Med Phys Fitness 39(3): 179-88.
Steenge GR, Simpson EJ, Greenhaff PL. Protein- and carbohydrate-induced augmentation of whole body creatine retention in humans. J Appl Physiol 2000 Sep;89(3):1165-71
Tarnopolsky M. A. 2000. Gender differences in metabolism; nutrition and supplements. J Sci Med Sport 3(3): 287-98.
Tarnopolsky M. A. G. Parise N. J. Yardley C. S. Ballantyne S. Olatinji and S. M. Phillips 2001. Creatine-dextrose and protein-dextrose induce similar strength gains during training. Med Sci Sports Exerc 33(12): 2044-52.
Volek J. S. N. D. Duncan S. A. Mazzetti M. Putukian A. L. Gomez and W. J. Kraemer 2000. No effect of heavy resistance training and creatine supplementation on blood lipids. Int J Sport Nutr Exerc Metab 10(2): 144-56.
Volek JS, Duncan ND, Mazzetti SA, Staron RS, Putukian M, Gomez AL, Pearson DR, Fink WJ, Kraemer WJ. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc 1999 Aug;31(8):1147-56
Waldegger S, Busch GL, Kaba NK, Zempel G, Ling H, Heidland A, Haussinger D, Lang F. Effect of cellular hydration on protein metabolism. Miner Electrolyte Metab 1997;23(3-6):201-5
Watanabe A, Kato N, Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res 2002 Apr;42(4):279-85
Yu P. H. and Y. Deng 2000. Potential cytotoxic effect of chronic administration of creatine a nutrition supplement to augment athletic performance. Med Hypotheses 54(5): 726-8.
Abel T. B. Knechtle C. Perret P. Eser P. von Arx and H. Knecht. 2005. Influence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized double-blind placebo-controlled study. Int J Sports Med 26(5): 344-9.
Ardite E. J. A. Barbera J. Roca and J. C. Fernandez-Checa. 2004. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation. Am J Pathol 165(3): 719-28.
Bachetti T. L. Comini G. Francolini D. Bastianon B. Valetti M. Cadei P. Grigolato H. Suzuki D. Finazzi A. Albertini S. Curello and R. Ferrari. 2004. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol 37(2): 515-23.
Bartok C. D. A. Schoeller J. C. Sullivan R. R. Clark and G. L. Landry. 2004. Hydration testing in collegiate wrestlers undergoing hypertonic dehydration. Med Sci Sports Exerc 36(3): 510-7.
Batshaw M. L. M. Walser and S. W. Brusilow. 1980. Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma. Pediatr Res 14(12): 1316-9.
Bendahan D Mattei JP Ghattas B et al. 2002. Citrulline/malate promotes aerobic energy production in human exercising muscle. Br J Sports Med; 36(4):282-9.
Bergero D. A. Assenza A. Schiavone G. Piccione G. Perona and G. Caola. 2005. Amino acid concentrations in blood serum of horses performing long lasting low-intensity exercise. J Anim Physiol Anim Nutr. Berl) 89(3-6): 146-50.
Berthold H. K. P. J. Reeds and P. D. Klein. 1995. Isotopic evidence for the differential regulation of arginine and proline synthesis in man. Metabolism 44(4): 466-73.
Blachier F. A. Mourtada R. Gomis A. Sener and W. J. Malaisse. 1991. Metabolic and secretory response of parotid cells to cationic amino acids. Uptake and catabolism of L-arginine and L-ornithine. Biochim Biophys Acta 1091(2): 151-7.
Blumenthal K. M. and E. L. Smith. 1975. Functional arginine residues involved in coenzyme binding by glutamate dehydrogenases. J Biol Chem 250(16): 6555-9.
Briand J Blehaut H Calvayrac R Laval-Martin D. 1992. Use of a microbial model for the determination of drug effects on cell metabolism and energetics: study of citrulline-malate. Biopharm Drug Dispos; 13(1):1-22.
Buford B. N. and A. J. Koch. 2004. Glycine-arginine-alpha-ketoisocaproic acid improves performance of repeated cycling sprints. Med Sci Sports Exerc 36(4): 583-7.
Callis A Magnan de Bornier B Serrano JJ et al. 1991. Activity of citrulline malate on acid-base balance and blood ammonia and amino acid levels. Study in the animal and in man. Arzneimittelforschung; 41(6):660-3.
Campbell E. J. M. A. Campbell and C. A. Owen. 2000. Bioactive proteinase 3 on the cell surface of human neutrophils: quantification catalytic activity and susceptibility to inhibition. J Immunol 165(6): 3366-74.
Chang C. I. J. C. Liao and L. Kuo. 2001. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61(3): 1100-6.
Chang C. I. B. Zoghi J. C. Liao and L. Kuo. 2000. The involvement of tyrosine kinases cyclic AMP/protein kinase A and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. J Immunol 165(4): 2134-41.
Chies A. B. F. M. Correa C. R. de Andrade A. A. Rosa-e-Silva F. C. Pereira and A. M. de Oliveira. 2003. Vascular non-endothelial nitric oxide induced by swimming exercise stress in rats. Clin Exp Pharmacol Physiol 30(12): 951-7.
Chies A. B. A. M. de Oliveira F. C. Pereira C. R. de Andrade and F. M. Correa. 2004. Phenylephrine-induced vasoconstriction of the rat superior mesenteric artery is decreased after repeated swimming. J Smooth Muscle Res 40(6): 249-58.
Chromiak J. A. and J. Antonio. 2002. Use of amino acids as growth hormone-releasing agents by athletes. Nutrition 18(7-8): 657-61.
Cicala A. and G. Ambrosanio. 1965. [On the use of a preparation of acetylaspartic acid and citrullin in aeronautic sport practice]. Minerva Med 56(90): 3850-4.
Cooper T. S. P. Laurent C. J. Moody and A. K. Takle. 2004. Asymmetric synthesis of N-protected amino acids by the addition of organolithium carboxyl synthons to ROPHy/SOPHy-derived aldoximes and ketoximes. Org Biomol Chem 2(2): 265-76.
Creager M. A.. 2001. Medical management of peripheral arterial disease. Cardiol Rev 9(4): 238-45.
Crisma M. A. Moretto F. Formaggio B. Kaptein Q. B. Broxterman and C. Toniolo. 2004. Meteoritic C alpha-methylated alpha-amino acids and the homochirality of life: searching for a link. Angew Chem Int Ed Engl 43(48): 6695-9.
Cronin C. N. and J. F. Kirsch. 1988. Role of arginine-292 in the substrate specificity of aspartate aminotransferase as examined by site-directed mutagenesis. Biochemistry 27(12): 4572-9.
Cuisinier C. R. J. Ward M. Francaux X. Sturbois and P. de Witte. 2001. Changes in plasma and urinary taurine and amino acids in runners immediately and 24h after a marathon. Amino Acids 20(1): 13-23.
Cynober L.. 1994. Can arginine and ornithine support gut functions? Gut 35(1 Suppl): S42-5.
Cynober L.. 2004. Ornithine alpha-ketoglutarate as a potent precursor of arginine and nitric oxide: a new job for an old friend. J Nutr 134(10 Suppl): 2858S-2862S; discussion 2895S.
Cynober L. A.. 2001. Do we have unrealistic expectations of the potential of immuno-nutrition? Can J Appl Physiol 26 Suppl: S36-44.
Dalhus B. and C. H. Gorbitz. 1999. Molecular aggregation in crystalline 1:1 complexes of hydrophobic D- and L-amino acids. I. The L-isoleucine series. Acta Crystallogr B 55(Pt 3): 424-431.
Dangel B. D. J. A. Johnson and D. Sames. 2001. Selective functionalization of amino acids in water: a synthetic method via catalytic C-H bond activation. J Am Chem Soc 123(33): 8149-50.
De Bandt J. P. L. Cynober S. K. Lim C. Coudray-Lucas R. Poupon and J. Giboudeau. 1995. Metabolism of ornithine alpha-ketoglutarate and arginine in isolated perfused rat liver. Br J Nutr 73(2): 227-39.
De Bandt J. P. and L. A. Cynober. 1998. Amino acids with anabolic properties. Curr Opin Clin Nutr Metab Care 1(3): 263-72.
Djeraba A. E. Musset N. van Rooijen and P. Quere. 2002. Resistance and susceptibility to Marek's disease: nitric oxide synthase/arginase activity balance. Vet Microbiol 86(3): 229-44.
Dolinska M. and J. Albrecht. 1997. Glutamate uptake is inhibited by L-arginine in mitochondria isolated from rat cerebrum. Neuroreport 8(9-10): 2365-8.
Ebner K. C. T. Wotjak R. Landgraf and M. Engelmann. 2002. Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats. Eur J Neurosci 15(2): 384-8.
Eymann C. G. Homuth C. Scharf and M. Hecker. 2002. Bacillus subtilis functional genomics: global characterization of the stringent response by proteome and transcriptome analysis. J Bacteriol 184(9): 2500-20.
Fornaris E Vanuxem J Duflot P et al. 1984. [Pharmacological/clinical approach of citrulline malate activity: study of blood lactate levels during standardized muscular exercise]. Gazette Medicale 91(11):125-128.
Fujioka M. and Y. Takata. 1981. Role of arginine residue in saccharopine dehydrogenase. L-lysine forming) from baker's yeast. Biochemistry 20(3): 468-72.
Fukuda H. T. Ogawa M. Tazaki K. Nagahama T. Fujii S. Tanase and Y. Morino. 1992. Two reactions are simultaneously catalyzed by a single enzyme: the arginine-dependent simultaneous formation of two products ethylene and succinate from 2-oxoglutarate by an enzyme from Pseudomonas syringae. Biochem Biophys Res Commun 188(2): 483-9.
Fullbright G. and E. E. Bullesbach. 2000. The receptor binding conformation of bombyxin is induced by alanine B15. Biochemistry 39(32): 9718-24.
Garcia-Santos Mdel P. S. Gonzalez-Mancebo J. Hernandez-Benito E. Calle and J. Casado. 2002. Reactivity of amino acids in nitrosation reactions and its relation to the alkylating potential of their products. J Am Chem Soc 124(10): 2177-82.
Glomb M. A. and G. Lang. 2001. Isolation and characterization of glyoxal-arginine modifications. J Agric Food Chem 49(3): 1493-501.
Goubel F Vanhoutte C Allaf O et al. 1997. Citrulline malate limits increase in muscle fatigue induced by bacterial endotoxins. Can J Physiol Pharmacol; 75(3):205-7.
Green D. C. Cheetham L. Mavaddat K. Watts M. Best R. Taylor and G. O'Driscoll. 2002. Effect of lower limb exercise on forearm vascular function: contribution of nitric oxide. Am J Physiol Heart Circ Physiol 283(3): H899-907.
Harkin A. T. J. Connor M. P. Burns and J. P. Kelly. 2004. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol 14(4): 274-81.
Hartman WJ Torre PM Prior RL. 1994. Dietary citrulline but not ornithine counteracts dietary arginine deficiency in rats by increasing splanchnic release of citrulline. J Nutr; 124(10):1950-60.
Hashim S. D. H. Kwon A. Abdelal and C. D. Lu. 2004. The arginine regulatory protein mediates repression by arginine of the operons encoding glutamate synthase and anabolic glutamate dehydrogenase in Pseudomonas aeruginosa. J Bacteriol 186(12): 3848-54.
Heiberg I. L. G. Wegener and R. Rosenberg. 2002. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav Brain Res 134(1-2): 479-84.
Heinrich A. M. Maheswaran U. Ruppert and K. Forchhammer. 2004. The Synechococcus elongatus P signal transduction protein controls arginine synthesis by complex formation with N-acetyl-L-glutamate kinase. Mol Microbiol 52(5): 1303-14.
Herranz Jordan B. F. Moreno Romero J. J. Cardesa Garcia I. Santos Hurtado A. Aparicio Palomino and F. Requena Guerrero. 1993. [Controlled clinical assay in Clonidine arginine aspartate alpha-ketoglutarate of Ornithine and Ciproheptadine as growth stimulants in children with short stature]. An Esp Pediatr 38(6): 509-15.
Hirsila M. P. Koivunen V. Gunzler K. I. Kivirikko and J. Myllyharju. 2003. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278(33): 30772-80.
Hu Q. Y. J. N. Li D. Q. Song Y. L. Wang G. Bekesi I. Weisz and J. D. Jiang. 2004. Inhibition of human hepatocellular carcinoma by L-proline-m-bis. 2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride. MF13) in vitro and in vivo. Int J Oncol 25(5): 1289-96.
Hunter L. M. D. McLeod and C. A. Hutton. 2005. Synthesis of the beta-hydroxydopa-gamma-hydroxy-delta-sulfinylnorvaline component of ustiloxins A and B. Org Biomol Chem 3(5): 732-4.
Ikkert O. V. N. M. Kurhaliuk and S. K. Hordii. 2001. [Effect of L-arginine and N(omega)-nitro-L-arginine on oxidative phosphorylation and lipid peroxidation in rats with various tolerance to hypoxia under stressful conditions]. Ukr Biokhim Zh 73(6): 89-97.
Imai K. and Y. Tomita. 1974. Interaction of the alpha-ketoglutarate dehydrogenase complex with basic polypeptides. J Biochem. Tokyo) 75(4): 699-705.
Inan S. Y. I. Yalcin and F. Aksu. 2004. Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol Biochem Behav 77(3): 457-64.
Indolfi C. D. Torella C. Coppola A. Curcio F. Rodriguez A. Bilancio A. Leccia O. Arcucci M. Falco D. Leosco and M. Chiariello. 2002. Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Circ Res 91(12): 1190-7.
Ishii N. H. Ikenaga P. K. Carmines Y. Aoki Z. Ogawa T. Saruta and T. Suga. 2004. High glucose augments arginase activity and nitric oxide production in the renal cortex. Metabolism 53(7): 868-74.
Janeira MA Santos PJ. 1998. Citrulline malate effects on the aerobic-anaerobic threshold and in post-exercise blood lactate recovery. Med Sci Sports Exerc; 30(5 supp): abstract 881.
Jeevanandam M. C. K. Begay N. J. Holaday and S. R. Petersen. 1997. Nutritional and metabolic effects and significance of mild orotic aciduria during dietary supplementation with arginine or its organic salts after trauma injury in rats. Metabolism 46(7): 785-92.
Jiang J. D. H. Zhang J. N. Li J. Roboz W. B. Qiao J. F. Holland and G. Bekesi. 2001. High anticancer efficacy of L-proline-m-bis. 2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride. MF13) in vivo. Anticancer Res 21(3B): 1681-9.
Jorgensen H. U. Knigge A. Kjaer and J. Warberg. 2002. Serotonergic involvement in stress-induced vasopressin and oxytocin secretion. Eur J Endocrinol 147(6): 815-24.
Kang E. S. K. Ford G. Grokulsky Y. B. Wang T. M. Chiang and S. R. Acchiardo. 2000. Normal circulating adult human red blood cells contain inactive NOS proteins. J Lab Clin Med 135(6): 444-51.
Kaster M. P. P. K. Ferreira A. R. Santos and A. L. Rodrigues. 2005. Effects of potassium channel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res 165(2): 204-9.
Kemi O. J. P. M. Haram U. Wisloff and O. Ellingsen. 2004. Aerobic fitness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining. Circulation 109(23): 2897-904.
Khan L. A. G. R. Loria A. S. Ramirez R. A. Nicholas R. J. Miles and M. D. Fielder. 2005. Biochemical characterisation of some non fermenting non arginine hydrolysing mycoplasmas of ruminants. Vet Microbiol 109(1-2): 129-34.
Kindig C. A. P. McDonough H. H. Erickson and D. C. Poole. 2002. Nitric oxide synthase inhibition speeds oxygen uptake kinetics in horses during moderate domain running. Respir Physiol Neurobiol 132(2): 169-78.
Kishimoto K. T. Yoshimura K. Soda and N. Esaki. 1997. Mutation of arginine 98 which serves as a substrate-recognition site of D-amino acid aminotransferase can be partly compensated for by mutation of tyrosine 88 to an arginyl residue. J Biochem. Tokyo) 122(6): 1182-9.
Kovacs J. M. C. T. Mant and R. S. Hodges. 2006. Determination of intrinsic hydrophilicity/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effects. Biopolymers 84(3): 283-97.
Lacerda A. C. U. Marubayashi C. H. Balthazar and C. C. Coimbra. 2006. Evidence that brain nitric oxide inhibition increases metabolic cost of exercise reducing running performance in rats. Neurosci Lett 393(2-3): 260-3.
Le Boucher J. C. Coudray-Lucas E. Lasnier A. Jardel O. G. Ekindjian and L. A. Cynober. 1997. Enteral administration of ornithine alpha-ketoglutarate or arginine alpha-ketoglutarate: a comparative study of their effects on glutamine pools in burn-injured rats. Crit Care Med 25(2): 293-8.
Le Boucher J. Eurengbiol M. C. Farges R. Minet M. P. Vasson and L. Cynober. 1999. Modulation of immune response with ornithine A-ketoglutarate in burn injury: an arginine or glutamine dependency? Nutrition 15(10): 773-7.
Le Bricon T. C. Coudray-Lucas N. Lioret S. K. Lim F. Plassart L. Schlegel J. P. De Bandt R. Saizy J. Giboudeau and L. Cynober. 1997. Ornithine alpha-ketoglutarate metabolism after enteral administration in burn patients: bolus compared with continuous infusion. Am J Clin Nutr 65(2): 512-8.
Ledwidge R. and J. S. Blanchard. 1999. The dual biosynthetic capability of N-acetylornithine aminotransferase in arginine and lysine biosynthesis. Biochemistry 38(10): 3019-24.
Loi C. S. Nakib N. Neveux F. Arnaud-Battandier and L. Cynober. 2005. Ornithine alpha-ketoglutarate metabolism in the healthy rat in the postabsorptive state. Metabolism 54(8): 1108-14.
Martinez-Argudo I. R. Little and R. Dixon. 2004. A crucial arginine residue is required for a conformational switch in NifL to regulate nitrogen fixation in Azotobacter vinelandii. Proc Natl Acad Sci U S A 101(46): 16316-21.
Medelli J. J. Lounana and D. Hill. 2003. Variation in plasma amino acid concentrations during a cycling competition. J Sports Med Phys Fitness 43(2): 236-42.
Meneguello M. O. J. R. Mendonca A. H. Lancha Jr. and L. F. Costa Rosa. 2003. Effect of arginine ornithine and citrulline supplementation upon performance and metabolism of trained rats. Cell Biochem Funct 21(1): 85-91.
Miyazaki J. N. Kobashi M. Nishiyama and H. Yamane. 2001. Functional and evolutionary relationship between arginine biosynthesis and prokaryotic lysine biosynthesis through alpha-aminoadipate. J Bacteriol 183(17): 5067-73.
Moinard C. F. Caldefie S. Walrand C. Felgines M. P. Vasson and L. Cynober. 2000. Involvement of glutamine arginine and polyamines in the action of ornithine alpha-ketoglutarate on macrophage functions in stressed rats. J Leukoc Biol 67(6): 834-40.
Morris S. and A. M. Adamczewska. 2002. Utilisation of glycogen ATP and arginine phosphate in exercise and recovery in terrestrial red crabs Gecarcoidea natalis. Comp Biochem Physiol A Mol Integr Physiol 133(3): 813-25.
Nibeilliu M. E. and J. P. Malthouse. 2004. The stereospecificity and catalytic efficiency of the tryptophan synthase-catalysed exchange of the alpha-protons of amino acids. Biochem J 381(Pt 3): 847-52.
Nitenberg G. and P. Dechelotte. 2000. Is immune nutrition the Holy Grail for cancer patients? Nestle Nutr Workshop Ser Clin Perform Programme 4: 255-72; discussion 273.
Nozal M. J. J. L. Bernal M. L. Toribio J. C. Diego and A. Ruiz. 2004. Rapid and sensitive method for determining free amino acids in honey by gas chromatography with flame ionization or mass spectrometric detection. J Chromatogr A 1047(1): 137-46.
Ohtani M. K. Maruyama M. Sugita and K. Kobayashi. 2001. Amino acid supplementation affects hematological and biochemical parameters in elite rugby players. Biosci Biotechnol Biochem 65(9): 1970-6.
Ohtani M. M. Sugita and K. Maruyama. 2006. Amino acid mixture improves training efficiency in athletes. J Nutr 136(2): 538S-543S.
Olsson L. G. K. Swedberg A. L. Clark K. K. Witte and J. G. Cleland. 2005. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 26(8): 778-93.
Peijie C. L. Hongwu X. Fengpeng R. Jie and Z. Jie. 2003. Heavy load exercise induced dysfunction of immunity and neuroendocrine responses in rats. Life Sci 72(20): 2255-62.
Pujol G.. 2001. Gain no pain? Surviv News. Atlanta Ga): 14.
Riedel E. H. Hampl V. Steudle and M. Nundel. 1996. Calcium alpha-ketoglutarate administration to malnourished hemodialysis patients improves plasma arginine concentrations. Miner Electrolyte Metab 22(1-3): 119-22.
Roch-Arveiller M. M. Tissot C. Coudray-Lucas J. Fontagne J. Le Boucher J. P. Giroud and L. Cynober. 1996. Immunomodulatory effects of ornithine alpha-ketoglutarate in rats with burn injuries. Arch Surg 131(7): 718-23.
Rosa A. O. J. Lin J. B. Calixto A. R. Santos and A. L. Rodrigues. 2003. Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 144(1-2): 87-93.
Sabathie M. L. de Coninck P. Fabre and G. Michel. 1975. Use of diarginine alpha-ketoglutarate following abdominal surgery. Apropos of 30 cases. Sem Hop Ther 51(9): 457-8.
Schneid C. S. Darquy L. Cynober G. Reach and J. P. De Bandt. 2003. Effects of ornithine alpha-ketoglutarate on insulin secretion in rat pancreatic islets: implication of nitric oxide synthase and glutamine synthetase pathways. Br J Nutr 89(2): 249-57.
Schneid C. J. P. De Bandt L. Cynober E. Torres G. Reach and S. Darquy. 2003. In vivo induction of insulin secretion by ornithine alpha-ketoglutarate: involvement of nitric oxide and glutamine. Metabolism 52(3): 344-50.
Schreier H. J. T. M. Smith and R. W. Bernlohr. 1982. Regulation of nitrogen catabolic enzymes in Bacillus spp. J Bacteriol 151(2): 971-5.
Schuster H. M. C. Blanc C. Genthon P. Therond D. Bonnefont-Rousselot A. Le Tourneau J. P. De Bandt and L. Cynober. 2005. Does dietary ornithine alpha-ketoglutarate supplementation protect the liver against ischemia-reperfusion injury? Clin Nutr 24(3): 375-84.
Shi D. H. Morizono X. Yu L. Tong N. M. Allewell and M. Tuchman. 2001. Human ornithine transcarbamylase: crystallographic insights into substrate recognition and conformational changes. Biochem J 354(Pt 3): 501-9.
Stafeeva O. A. V. S. Gomazkova and S. E. Severin. 1980. Modification of arginine residues of alpha-ketoglutarate dehydrogenase by 2 3-butanedione. Dokl Akad Nauk SSSR 251(2): 497-9.
Stafeeva O. A. V. S. Gomazkova and S. E. Severin. 1983. Essential arginine residues for catalytic and regulatory functions of alpha-ketoglutarate dehydrogenase from pigeon breast muscle. Biochem Int 6(3): 315-21.
Tarr M. A. W. Wang T. S. Bianchi and E. Engelhaupt. 2001. Mechanisms of ammonia and amino acid photoproduction from aquatic humic and colloidal matter. Water Res 35(15): 3688-96.
Thibodeaux S. J. E. Billiot and I. M. Warner. 2002. Enantiomeric separations using poly(L-valine) and poly(L-leucine) surfactants. Investigation of steric factors near the chiral center. J Chromatogr A 966(1-2): 179-86.
Tuganowski W. and W. Zielinski. 1996. Inhibitory effects of O-benzyl-phosphocreatine ethyl ester in rabbit myocardium. J Mol Cell Cardiol 28(5): 845-9.
Valentincic T. and J. Caprio. 1997. Visual and chemical release of feeding behavior in adult rainbow trout. Chem Senses 22(4): 375-82.
van Rijn J. J. van den Berg T. Teerlink F. A. Kruyt D. S. Schor A. C. Renardel de Lavalette T. K. van den Berg C. Jakobs and B. J. Slotman. 2003. Changes in the ornithine cycle following ionising radiation cause a cytotoxic conditioning of the culture medium of H35 hepatoma cells. Br J Cancer 88(3): 447-54.
Vanuxem D Duflot JC Prevot H et al. 1990. Influence of an anti-astenia agent citrulline malate on serum lactate and ammonia kinetics during a maximum exercise test in sedentary subjects. Sem Hop Paris; 66(9):477-481.
Vermeij T. A. and P. M. Edelbroek. 2004. Simultaneous high-performance liquid chromatographic analysis of pregabalin gabapentin and vigabatrin in human serum by precolumn derivatization with o-phtaldialdehyde and fluorescence detection. Chromatogr B Analyt Technol Biomed Life Sci 810(2): 297-303.
Volke V. G. Wegener M. Bourin and E. Vasar. 2003. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res 140(1-2): 141-7.
Wang M. X. D. F. Murrell C. Szabo R. F. Warren M. Sarris and G. A. Murrell. 2001. Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats. Nitric Oxide 5(3): 219-32.
Wang X. G. K. L. Britton T. J. Stillman D. W. Rice and P. C. Engel. 2001. Conversion of a glutamate dehydrogenase into methionine/norleucine dehydrogenase by site-directed mutagenesis. Eur J Biochem 268(22): 5791-9.
Waugh WH Daeschner CW Files BA et al. 2001. Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc; 93(10):363-71.
Wheatley D. N. R. Philip and E. Campbell. 2003. Arginine deprivation and tumour cell death: arginase and its inhibition. Mol Cell Biochem 244(1-2): 177-85.
Wisloff U. R. S. Richardson and A. O. Brubakk. 2004. Exercise and nitric oxide prevent bubble formation: a novel approach to the prevention of decompression sickness? J Physiol 555(Pt 3): 825-9.
Wright S. K. and R. E. Viola. 2001. Alteration of the specificity of malate dehydrogenase by chemical modulation of an active site arginine. J Biol Chem 276(33): 31151-5.
Yang H. M. Wiren J. Larsson and J. Permert. 1999. Whole-protein-based enteral formula stimulates intestinal ornithine decarboxylase activity more than single amino acids but does not affect mucosal adenosine triphosphate content in early postsurgical refeeding. JPEN J Parenter Enteral Nutr 23(4): 207-12.
Yasuda M. K. Tanizawa H. Misono S. Toyama and K. Soda. 1981. Properties of crystalline L-ornithine: alpha-ketoglutarate delta-aminotransferase from Bacillus sphaericus. J Bacteriol 148(1): 43-50.
Yin X. T. O'Hare S. J. Gould and T. M. Zabriskie. 2003. Identification and cloning of genes encoding viomycin biosynthesis from Streptomyces vinaceus and evidence for involvement of a rare oxygenase. Gene 312: 215-24.
Zhang Z. J. Ren D. K. Stammers J. E. Baldwin K. Harlos and C. J. Schofield. 2000. Structural origins of the selectivity of the trifunctional oxygenase clavaminic acid synthase. Nat Struct Biol 7(2): 127-33.
Aarts, E. M. and C. Hinnen-Bouwmans. 1972. Common properties of D-glucuronolactone and aldehyde dehydrogenase from the soluble fraction of rat liver. Biochim Biophys Acta 268(1): 21-9.
Alford, C., H. Cox and R. Wescott. 2001. The effects of red bull energy drink on human performance and mood. Amino Acids 21(2): 139-50.
Alsene K Deckert J Sand P de Wit H. 2003. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. Sep;28(9):1694-702 epubJun 25
Arevalo, R., R. Castro, M. D. Palarea and M. Rodriguez. 1987. Tyrosine administration to pregnant rats induces persistent behavioral modifications in the male offspring. Physiol Behav 39(4): 477-81.
Armstrong LE. 2002. Caffeine body fluid-electrolyte balance and exercise performance. Int J Sport Nutr Exerc Metab. Jun;12(2):189-206
Austin, M. C., S. L. Cottingham, S. M. Paul and J. N. Crawley. 1990. Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration. Synapse 6(4): 351-7.
Beaumont M Batejat D Pierard C Coste O Doireau P Van Beers P Chauffard F Chassard D Enslen M Denis JB Lagarde D. 2001. Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance. J Sleep Res. Dec;10(4):265-76
Bell DG McLellan TM. 2002. Exercise endurance 1 3 and 6 h after caffeine ingestion in caffeine users and nonusers. J Appl Physiol. Oct;93(4):1227-34
Bergering A. and H. Lobb. 1969. Effects of stimulant drugs on maze swimming. Psychol Rep 24(3): 947-50.
Bergero, D., A. Assenza, A. Schiavone, G. Piccione, G. Perona and G. Caola. 2005. Amino acid concentrations in blood serum of horses performing long lasting low-intensity exercise. J Anim Physiol Anim Nutr. Berl) 89(3-6): 146-50.
Binder, W., S. A. Mousa, N. Sitte, M. Kaiser, C. Stein and M. Schafer. 2004. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. Eur J Neurosci 20(1): 92-100.
Blomstrand, E. and B. Saltin. 1999. Effect of muscle glycogen on glucose, lactate and amino acid metabolism during exercise and recovery in human subjects. J Physiol 514. Pt 1): 293-302.
Blomstrand, E. and E. A. Newsholme. 1992. Effect of branched-chain amino acid supplementation on the exercise-induced change in aromatic amino acid concentration in human muscle. Acta Physiol Scand 146(3): 293-8.
Bolivar, V. J., K. Manley and J. C. Fentress. 1996. The development of swimming behavior in the neurological mutant weaver mouse. Dev Psychobiol 29(2): 123-37.
Bonsignore, M. R., G. Morici, A. Santoro, M. Pagano, L. Cascio, A. Bonanno, P. Abate, F. Mirabella, M. Profita, G. Insalaco, M. Gioia, A. M. Vignola, I. Majolino, U. Testa and J. C. Hogg. 2002. Circulating hematopoietic progenitor cells in runners. J Appl Physiol 93(5): 1691-7.
Boyer M. S. Rees J. Quinn K. Grattan-Miscio M. McCallum and M. J. Saari. 2003. Caffeine as a performance-enhancing drug in rats: sex dose housing and task considerations. Percept Mot Skills 97(1): 259-70.
Cai Q Dmitrieva NI Michea LF Rocha G Ferguson D Burg MB. 2003. Toxicity of acetaminophen salicylic acid and caffeine for first-passage rat renal inner medullary collecting duct cells. J Pharmacol Exp Ther. Jul;306(1):35-42 epubMar 27
Carrillo JA Benitez J. 2000. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. Aug;39(2):127-53
Cauli O Morelli M. 2002. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists. Psychopharmacology (Berl). Jul;162(3):246-54 epubMay 14
Cha YS Choi SK Suh H Lee SN Cho D Li K. 2001. Effects of carnitine coingested caffeine on carnitine metabolism and endurance capacity in athletes. J Nutr Sci Vitaminol (Tokyo). Dec;47(6):378-84
Chantre P Lairon D. 2002. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine. Jan;9(1):3-8
Chinevere, T. D., R. D. Sawyer, A. R. Creer, R. K. Conlee and A. C. Parcell. 2002. Effects of L-tyrosine and carbohydrate ingestion on endurance exercise performance. J Appl Physiol 93(5): 1590-7.
Christensen M Tybring G Mihara K Yasui-Furokori N Carrillo JA Ramos SI Andersson K Dahl ML Bertilsson L. 2002. Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). Clin Pharmacol Ther. Mar;71(3):141-52
Conlay, L. A., L. A. Sabounjian and R. J. Wurtman. 1992. Exercise and neuromodulators: choline and acetylcholine in marathon runners. Int J Sports Med 13 Suppl 1: S141-2.
Conlay, L. A., R. J. Wurtman, G. C. I. Lopez, J. K. Blusztajn, C. A. Vacanti, M. Logue, M. During, B. Caballero, T. J. Maher and G. Evoniuk. 1989. Effects of running the Boston marathon on plasma concentrations of large neutral amino acids. J Neural Transm 76(1): 65-71.
Cox GR Desbrow B Montgomery PG Anderson ME Bruce CR Macrides TA Martin DT Moquin A Roberts A Hawley JA Burke LM. 2002. Effect of different protocols of caffeine intake on metabolism and endurance performance. J Appl Physiol. Sep;93(3):990-9
Coyle E. F.. 1984. Ergogenic aids. Clin Sports Med 3(3): 731-42.
Davydova, N. A., A. Senkevich Iu, M. S. Belakovskii and S. V. Samratova. 1985. Catecholamine metabolism in a high-altitude environment. Kosm Biol Aviakosm Med 19(4): 60-3.
Dews PB O'Brien CP Bergman J. 2002. Caffeine: behavioral effects of withdrawal and related issues. Food Chem Toxicol. Sep;40(9):1257-61
Di Filippo, N. M. and H. J. Blumenthal. 1972. Experimental cholelithiasis in the golden hamster: effect of glucuronolactone. J Am Osteopath Assoc 72(3): 288-93.
Diamond S Freitag FG. 2001. The use of ibuprofen plus caffeine to treat tension-type headache. Curr Pain Headache Rep. Oct;5(5):472-8
Dinic M.. 1965. Determination Of Antipyrine Citrate And Caffine In Powders And Tablets.. Vojnosanit Pregl 22: 11-5.
Doherty M Smith PM Davison RC Hughes MG. 2002. Caffeine is ergogenic after supplementation of oral creatine monohydrate. Med Sci Sports Exerc. Nov;34(11):1785-92
Dunagan N Greenleaf JE Cisar CJ. 1998. Thermoregulatory effects of caffeine ingestion during submaximal exercise in men. Aviat Space Environ Med. Dec;69(12):1178-81
Elgjo K.. 1975. Epidermal chalone and cyclic AMP: an in vivo study. J Invest Dermatol 64(1): 14-8.
Elovaara, E., K. Engstrom, J. Nickels, A. Aito and H. Vainio. 1985. Biochemical and morphological effects of long-term inhalation exposure of rats to ethylbenzene. Xenobiotica 15(4): 299-308.
Evangelista, S., F. Borsini and A. Meli. 1987. Evidence that muscimol acts in the forced swimming test by activating the rat dopaminergic system. Life Sci 41(24): 2679-84.
Gauchard G. C. A. Tessier C. Jeandel and P. P. Perrin. 2003. Improved muscle strength and power in elderly exercising regularly. Int J Sports Med 24(1): 71-4.
Georgescu, D., R. M. Sears, J. D. Hommel, M. Barrot, C. A. Bolanos, D. J. Marsh, M. A. Bednarek, J. A. Bibb, E. Maratos-Flier, E. J. Nestler and R. J. DiLeone. 2005. The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J Neurosci 25(11): 2933-40.
Gil, M., J. Marti and A. Armario. 1992. Inhibition of catecholamine synthesis depresses behavior of rats in the holeboard and forced swim tests: influence of previous chronic stress. Pharmacol Biochem Behav 43(2): 597-601.
Gruber A. J. and H. G. Pope Jr.. 1998. Ephedrine abuse among 36 female weightlifters. Am J Addict 7(4): 256-61.
Guerra, A., C. Rego, M. J. Laires, E. M. Castro, D. Silva, C. Monteiro, Z. Silva, E. Lebre and M. Bicho. 2001. Lipid profile and redox status in high performance rhythmic female teenagers gymnasts. J Sports Med Phys Fitness 41(4): 505-12.
Hansen, P. A., L. A. Nolte, M. M. Chen and J. O. Holloszy. 1998. Increased GLUT-4 translocation mediates enhanced insulin sensitivity of muscle glucose transport after exercise. J Appl Physiol 85(4): 1218-22.
Hayashi, S., M. Watanabe and A. Kimura. 1984. Enzymatic determination of free glucuronic acid with glucuronolactone reductase. I. Isolation and purification of glucuronolactone reductase from rat kidney. J Biochem. Tokyo) 95(1): 223-32.
Hayashi, S., M. Watanabe and A. Kimura. 1984. Enzymatic determination of free glucuronic acid with glucuronolactone reductase. II. Procedure for the enzymatic determination of glucuronic acid and its application to degradation studies of glycosaminoglycans. J Biochem. Tokyo) 95(1): 233-8.
Hennies, H. H. and L. Flohe. 1985. Influence of sedatives on stress-induced trans-synaptic induction of tyrosine hydroxylase. Arzneimittelforschung 35(1): 112-5.
Hespel P Op't Eijnde B Van Leemputte M. 2002. Opposite actions of caffeine and creatine on muscle relaxation time in humans. J Appl Physiol. Feb;92(2):513-8
Hinohara, Y., S. Takanashi, R. Nagashima and A. Shioya. 1974. Glucuronic acid pathway in alloxan diabetic rabbits.. I. Urinary excretion of metabolites related to the glucuronic acid pathway. Jpn J Pharmacol 24(6): 869-78.
Hogervorst E Riedel WJ Kovacs E Brouns F Jolles J. 1999. Caffeine improves cognitive performance after strenuous physical exercise. Int J Sports Med. Aug;20(6):354-61
Hongu N Sachan DS. 2000. Caffeine carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exercise. J Nutr. Feb;130(2):152-7
Horne, J. A. and L. A. Reyner. 2001. Beneficial effects of an energy drink given to sleepy drivers. Amino Acids 20(1): 83-9.
Hsu, J. M. and H. S. Hsieh. 1981. Effects of ethionine feeding on urinary and tissue ascorbic acid concentrations in rats. J Nutr 111(1): 141-5.
Hundt H. K. P. J. van der Merwe and D. J. van Velden. 1984. Drugs in sport. A report of laboratory investigations into the prevalence of their use in South Africa. S Afr Med J 66(23): 878-81.
Jessen AB Toubro S Astrup A. 2003. Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men. Am J Clin Nutr. Jun;77(6):1442-7
Johnson-Kozlow M Kritz-Silverstein D Barrett-Connor E Morton D. 2002. Coffee consumption and cognitive function among older adults. Am J Epidemiol. Nov 1;156(9):842-50
Jones A. R. and J. T. Pichot. 1998. Stimulant use in sports. Am J Addict 7(4): 243-55.
Jones HE Griffiths RR. 2003. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers. Psychopharmacology (Berl). Jan;165(3):280-90 epubNov 14
Karpus, O. V., V. A. Rogozkin, E. A. Mel'gunova and B. I. Fel'dkoren. 1993. The effect of systematic physical loading and of a high-carbohydrate diet on the level of glycosylated proteins in the blood of rats. Fiziol Zh Im I M Sechenova 79(12): 39-43.
Kawamata, M.. 1971. Glucuronic acid metabolism. 22. Pharmacological studies on thiopental sodium anesthesia. Effects of glucuronolactone on thiopental sodium anesthesia. Nippon Yakurigaku Zasshi 67(1): 75-82.
Keogh E Chaloner N. 2002. The moderating effect of anxiety sensitivity on caffeine-induced hypoalgesia in healthy women. Psychopharmacology (Berl). Dec;164(4):429-31 epubOct 24
Kogure A Sakane N Takakura Y Umekawa T Yoshioka K Nishino H Yamamoto T Kawada T Yoshikawa T Yoshida T. 2002. Effects of caffeine on the uncoupling protein family in obese yellow KK mice. Clin Exp Pharmacol Physiol. May-Jun;29(5-6):391-4
Kovacs EM Stegen JHCH Brouns F. 1998. Effect of caffeinated drinks on substrate metabolism caffeine excretion and performance. J Appl Physiol. Aug;85(2):709-15
Kuzuya, T., Y. Kanazawa, M. Kikuchi and T. Ide. 1973. Effects of D-glucuronolactone, L-gulonolactone and penitols on insulin secretion in dogs. Endocrinol Jpn 20(4): 369-74.
Lee C. 2000. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin Chim Acta. May;295(1-2):141-54
Lehmann, M., H. Mann, U. Gastmann, J. Keul, D. Vetter, J. M. Steinacker and D. Haussinger. 1996. Unaccustomed high-mileage vs intensity training-related changes in performance and serum amino acid levels. Int J Sports Med 17(3): 187-92.
Lehmann, M., M. Huonker, F. Dimeo, N. Heinz, U. Gastmann, N. Treis, J. M. Steinacker, J. Keul, R. Kajewski and D. Haussinger. 1995. Serum amino acid concentrations in nine athletes before and after the 1993 Colmar ultra triathlon. Int J Sports Med 16(3): 155-9.
Lessenich, A., S. Lindemann, A. Richter, H. J. Hedrich, D. Wedekind, A. Kaiser and W. Loscher. 2001. A novel black-hooded mutant rat. ci3) with spontaneous circling behavior but normal auditory and vestibular functions. Neuroscience 107(4): 615-28.
Lieberman, H. R., J. H. Georgelis, T. J. Maher and S. K. Yeghiayan. 2005. Tyrosine prevents effects of hyperthermia on behavior and increases norepinephrine. Physiol Behav 84(1): 33-8.
Lim BV Jang MH Shin MC Kim HB Kim YJ Kim YP Chung JH Kim H Shin MS Kim SS Kim EH Kim CJ. 2001. Caffeine inhibits exercise-induced increase in tryptophan hydroxylase expression in dorsal and median raphe of Sprague-Dawley rats. Neurosci Lett. Jul 27;308(1):25-8
Lu YP Lou YR Lin Y Shih WJ Huang MT Yang CS Conney AH. 2001. Inhibitory effects of orally administered green tea black tea and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res. Jul 1;61(13):5002-9
Mackay M Tiplady B Scholey AB. 2002. Interactions between alcohol and caffeine in relation to psychomotor speed and accuracy. Hum Psychopharmacol. Apr;17(3):151-6
Marselos, M. and O. Hanninen. 1974. Enhancement of D-glucuronolactone and acetaldehyde dehydrogenase activities in the rat liver by inducers of drug metabolism. Biochem Pharmacol 23(10): 1457-66.
Marselos, M., M. Lang and R. Torronen. 1976. Modifications of drug metabolism by disulfiram and diethyldithiocarbamate. II. D-Glucuronic acid pathway. Chem Biol Interact 15(3): 277-87.
Masaki, H.. 1972. Metabolic pathway of D-glucaric acid synthesis from D-glucuronolactone in the skin. II. Identification of the intermediates in D-glucuronolactone D-glucaric acid metabolism. Nippon Hifuka Gakkai Zasshi 82(4): 233-8.
Medelli, J., J. Lounana and D. Hill. 2003. Variation in plasma amino acid concentrations during a cycling competition. J Sports Med Phys Fitness 43(2): 236-42.
Papadelis C Kourtidou-Papadeli C Vlachogiannis E Skepastianos P Bamidis P Maglaveras N Pappas K. 2003. Effects of mental workload and caffeine on catecholamines and blood pressure compared to performance variations. Brain Cogn. Feb;51(1):143-54
Piccardo, M., L. Russo and M. Rosa. 1979. Paper chromatography of the urinary carbohydrates in normal subjects: the aldoses. Boll Soc Ital Biol Sper 55(11): 1039-42.
Pierard C Beaumont M Enslen M Chauffard F Tan DX Reiter RJ Fontan A French J Coste O Lagarde D. 2001. Resynchronization of hormonal rhythms after an eastbound flight in humans: effects of slow-release caffeine and melatonin. Eur J Appl Physiol. Jul;85(1-2):144-50
Plaskett CJ Cafarelli E. 2001. Caffeine increases endurance and attenuates force sensation during submaximal isometric contractions. J Appl Physiol. Oct;91(4):1535-44
Pollak CP Bright D. 2003. Caffeine consumption and weekly sleep patterns in US seventh- eighth- and ninth-graders. Pediatrics. Jan;111(1):42-6
Poon, R., D. C. Villeneuve, I. Chu and R. Kinach. 1993. HPLC determination of D-glucaric acid in human urine. J Anal Toxicol 17(3): 146-50.
Radak, Z., H. Ogonovszky, J. Dubecz, G. Pavlik, M. Sasvari, J. Pucsok, I. Berkes, T. Csont and P. Ferdinandy. 2003. Super-marathon race increases serum and urinary nitrotyrosine and carbonyl levels. Eur J Clin Invest 33(8): 726-30.
Reyner, L. A. and J. A. Horne. 2002. Efficacy of a 'functional energy drink' in counteracting driver sleepiness. Physiol Behav 75(3): 331-5.
Riesselmann, B., F. Rosenbaum and V. Schneider. 1996. Alcohol and energy drink--can combined consumption of both beverages modify automobile driving fitness?. Blutalkohol 33(4): 201-8.
Rogers PJ Martin J Smith C Heatherley SV Smit HJ. 2003. Absence of reinforcing mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Psychopharmacology (Berl). Apr;167(1):54-62 epubFeb 25
Rostrup, M.. 1998. Catecholamines, hypoxia and high altitude. Acta Physiol Scand 162(3): 389-99.
Santalla A Lucia A Perez M. 2001. Caffeine ingestion attenuates the VO(2) slow component during intense exercise. Jpn J Physiol. Dec;51(6):761-4
Scott, P. A., M. A. Cierpial, C. D. Kilts and J. M. Weiss. 1996. Susceptibility and resistance of rats to stress-induced decreases in swim-test activity: a selective breeding study. Brain Res 725(2): 217-30.
Seidl, R., A. Peyrl, R. Nicham and E. Hauser. 2000. A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids 19(3-4): 635-42.
Smirnoff, N.. 2001. L-ascorbic acid biosynthesis. Vitam Horm 61: 241-66.
Smith A. 2002. Effects of caffeine on human behavior. Food Chem Toxicol. Sep;40(9):1243-55
Stine MM O'Connor RJ Yatko BR Grunberg NE Klein LC. 2002. Evidence for a relationship between daily caffeine consumption and accuracy of time estimation. Hum Psychopharmacol. Oct;17(7):361-7
Sutton, E. E., M. R. Coill and P. A. Deuster. 2005. Ingestion of tyrosine: effects on endurance, muscle strength, and anaerobic performance. Int J Sport Nutr Exerc Metab 15(2): 173-85.
Suzuki, S., S. Hayase, M. Nakano, Y. Oda and K. Kakehi. 1998. Analysis of glucuronolactone and glucuronic acid in drug formulations by high-performance liquid chromatography. J Chromatogr Sci 36(7): 357-60.
Tang K. W. C. S. Zhou S. A. Zhong and J. D. Zhu. 2003. Study on adsorption of tea polyphenol and caffine with polyamide resin. Guang Pu Xue Yu Guang Pu Fen Xi 23(1): 143-5.
Tarnopolsky M Cupido C. 2000. Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers. J Appl Physiol. Nov;89(5):1719-24
Tharion WJ Shukitt-Hale B Lieberman HR. 2003. Caffeine effects on marksmanship during high-stress military training with 72 hour sleep deprivation. Aviat Space Environ Med. Apr;74(4):309-14
Thong FS Graham TE. 2002. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol. Jun;92(6):2347-52
Tonkes, P. G. and C. A. Marsh. 1973. Substrate specificity of mammalian D-glucuronolactone dehydrogenase. Aust J Biol Sci 26(4): 839-49.
Torronen, R. and M. Marselos. 1977. Comparison of D-glucuronolactone and aldehyde dehydrogenase activities in the rat liver. Med Biol 55(2): 95-100.
Tsao, C. S. and M. Young. 1990. Enzymatic formation of ascorbic acid in liver homogenate of mice fed dietary ascorbic acid. In Vivo 4(3): 167-9.
van den Baar, M. T., D. Fekkes, C. R. van den Hoogenband, H. J. Duivenvoorden and L. Pepplinkhuizen. 2004. Plasma amino acids and sports injuries. Amino Acids 26(1): 71-6.
van der Merwe P. J. and H. S. Kruger. 1992. Drugs in sport--results of the past 6 years of dope testing in South Africa. S Afr Med J 82(3): 151-3.
van der Merwe P. J. H. K. Hundt F. O. Muller and D. P. van Velden. 1988. Drugs in sport. The first 5 years of testing in South Africa. S Afr Med J 74(4): 161-2.
van Loon, L. J., M. Kruijshoop, H. Verhagen, W. H. Saris and A. J. Wagenmakers. 2000. Ingestion of protein hydrolysate and amino acid-carbohydrate mixtures increases postexercise plasma insulin responses in men. J Nutr 130(10): 2508-13.
Varrik, E., A. Viru, V. Oopik and M. Viru. 1992. Exercise-induced catabolic responses in various muscle fibres. Can J Sport Sci 17(2): 125-8.
Verhoef P Pasman WJ Van Vliet T Urgert R Katan MB. 2002. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Am J Clin Nutr. Dec;76(6):1244-8
Volkheimer G. F. H. Schulz E. Hofer and J. Schicht. 1969. Effect of caffine on the rate of persorption. Nutr Dieta Eur Rev Nutr Diet 11(1): 13-22.
Wagenmakers, A. J.. 1999. Amino acid supplements to improve athletic performance. Curr Opin Clin Nutr Metab Care 2(6): 539-44.
Warburton, D. M., E. Bersellini and E. Sweeney. 2001. An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence. Psychopharmacology. Berl) 158(3): 322-8.
Watson J Deary I Kerr D. 2002. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. Br J Clin Pharmacol. Oct;54(4):400-6
Wesensten NJ Belenky G Kautz MA Thorne DR Reichardt RM Balkin TJ. 2002. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl). Jan;159(3):238-47 epubOct 19
Yoshioka M Doucet E Drapeau V Dionne I Tremblay A. 2001. Combined effects of red pepper and caffeine consumption on 24 h energy balance in subjects given free access to foods. Br J Nutr. Feb;85(2):203-11